Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

LUNG CANCER(2023)

引用 0|浏览11
暂无评分
关键词
egfr exon,metastatic nsclc,mnsclc,mobocertinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要